All News

Das Bild zeigt in rot die Akkumulation von GIP im Hirnstamm nach einmaliger peripherer Injektion und in grün die dadurch bewirkte Aktivierung von Neuronen. in Zusammenhang mit der Publikation Liskiewicz et al. (2023): Glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via GABAergic neurons in mice. Nature Metabolism.

New Research Findings, Diabetes, IDO,

Understanding the Role of GIP in Managing Diabetes and Obesity

The increasing amount of patients with obesity and type 2 diabetes benefit greatly from the recently developed GIPR:GLP-1R co-agonists. These novel compounds lead to substantial weight loss, offering a revolutionary approach to patients worldwide.…

Matthias Tschöp receives Heinrich Wieland Price 2023

Awards & Grants, Diabetes, IDO,

"Reversing the Pandemic of Obesity and Diabetes"

Heinrich Wieland Prize for Matthias Tschöp: Breakthrough in the battle against obesity and diabetes

IDO, Institute for Diabetes and Obesity

Awards & Grants, Diabetes, IDO,

Regulation of Energy and Glucose Metabolism: Timo Müller Honored with Minkowski Prize Awarded by the EASD

Diabetes researcher Dr. Timo Müller was honored with the 58th Minkowski Prize awarded by the EASD for his distinction manifested by publications that contribute to the advancement of knowledge concerning diabetes.

Matthias H. Tschöp

Awards & Grants, Diabetes, IDO,

Transformative Drugs Discovered: Matthias Tschöp Wins Major US Award

For major breakthroughs, the American Diabetes Association (ADA) awards its highest honor, the Banting Medal for Scientific Achievement named after the nobel laureate and discoverer of insulin, Frederick Banting. Former CEO at Helmholtz Munich and…

IDO Labor Gelber Handschuh

New Research Findings, IDO,

Unraveling the Mode of Action of Tirzepatide

Tirzepatide is a recently approved treatment for type-2 diabetes. Treatment with tirzepatide decreases body weight while improving glucose metabolism in patients with obesity and type-2 diabetes. Although the drug is designed to activate receptors…

Timo Müller Werner-Creutzfeldt-Preis 2023 Auszeichnung, Mai 2023 Berlin

Awards & Grants, IDO,

Timo Müller Awarded with Werner Creutzfeldt Prize

The German Diabetes Society (DDG) awards this year's Werner Creutzfeldt Prize to Helmholtz Munich scientist PD Dr Timo Müller for his exceptional work in the research field of Incretin-based diabetes and obesity. This is already the second time in a…